Cobimetinib for BRAF-wild-type histiocytoses : a randomized, placebo-controlled, double blind study

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2018
This article has no abstract
Epistemonikos ID: 8b1785d9ee1df0057d76ceb7e4b083463bb19ee2
First added on: Jan 23, 2025